Skip to content

Trajectories of Chronic Multimorbidity Patterns in Older Patients

Trajectories of Chronic Multimorbidity Patterns in Patients >65 Years Old. MTOP

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05717309
Acronym
MTOP
Enrollment
3988
Registered
2023-02-08
Start date
2022-02-10
Completion date
2023-07-31
Last updated
2023-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Disease

Keywords

Multimorbidity, Cluster analysis, Trajectories, Older patient, COVID-19

Brief summary

Following the MRisk-COVID project, MTOP (Multimorbidity Trajectories in Older Patients) study was developed. It is a retrospective observational study using Real World Data that aims to identify patterns of chronic multimorbidity in patients aged ≥65 years and their evolution and trajectories in the previous 10 years. The secondary objective is to identify the relationship between the trajectories of multimorbidity patterns in the previous 10 years and the severity of the infection by COVID-19.

Detailed description

Multimorbidity is associated with negative results and presents difficulties in clinical management. Recently, new methodologies are emerging based on the hypothesis that chronic conditions are associated in a non-random way forming multimorbidity patterns. However, there are few studies that study the temporal evolution and trajectories of these multimorbidity patterns, which could be associated with different prognoses and could allow better forecasting and planning. The primary objective of this analysis is to identify patterns of chronic multimorbidity in patients aged ≥65 years and their evolution and trajectories in the previous 10 years, using part of the MRisk-COVID project data. As a secondary objective, the investigators want to identify the relationship between the trajectories of multimorbidity patterns in the previous 10 years and the severity of the COVID-19 infection. This retrospective observational study has a historical cohort of 3958 patients ≥65 years of age suspected and confirmed of COVID-19 infection from February 1 to June 15, 2020 in the reference area of Parc Taulí University Hospital. The available data (real-world data) are socio-demographic and diagnostic variables provided by the Data Analytics Program for Research and Innovation in Health (PADRIS), which include sex, age and primary care diagnoses. To identify patterns of multimorbidity, the Clinical Classification Software, Chronic Condition Indicator, multiple correspondence analysis and cluster analysis using the fuzzy c-means algorithm will be used. Then, a clinical consensus process (Delphi-like) will be made of the clusters obtained. To identify the most probable trajectories along the three time points, each patient will be assigned to the cluster with the highest probability of membership. Descriptive and bivariate statistics will be performed.

Interventions

None listed

Sponsors

Department of Health, Generalitat de Catalunya
CollaboratorOTHER_GOV
Corporacion Parc Tauli
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to 94 Years

Inclusion criteria

* Positive results of COVID-19 laboratory tests * COVID-19 related clinical profile verified by healthcare professionals

Exclusion criteria

* Males \>90 years (re-identification risk)

Design outcomes

Primary

MeasureTime frameDescription
Chronic multimorbidity patterns - Time Frame 1Baseline (2020)Obtained using fuzzy c-means cluster analysis
Chronic multimorbidity patterns - Time Frame 25 years before (2015)Obtained using fuzzy c-means cluster analysis
Chronic multimorbidity patterns - Time Frame 310 years before (2010)Obtained using fuzzy c-means cluster analysis
Trajectories of chronic multimorbidity patternsChange over 10 yearsObtained by assigning the highest probable cluster at each time point

Secondary

MeasureTime frameDescription
Severe COVID-19 infectionFrom 27-February-2020 to 15-June-2020Severe COVID-19 infection was defined as the occurrence of at least one of the following conditions during any of the registered COVID-19 episodes: severe respiratory affection (including insufficiency, failure, or distress); use of respiratory support (including mechanical ventilation or oxygen therapy); septic shock; multiple organ failure (the combination of respiratory failure and any other organ failure); inflammatory response; admission to intensive care unit; and mortality

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026